ASRM Responds to News of Birth Following Successful Uterus Transplant
Dec 04, 2017
Origin: ASRM Press Release
ASRM issued the following press release today.
Statement attributable to Christos Coutifaris, MD, PhD, President of the American Society for Reproductive Medicine.
Washington, DC- This birth represents another important milestone in the history of reproductive medicine.
Uterine factor infertility is estimated to affect 1 in 500 women of reproductive age and can result from either congenital absence of a uterus or from a nonfunctional or surgically absent uterus . For these women uterus transplantation represents the only way they can carry a pregnancy. In addition to the medical indications, uterus transplantation presents an important option for those living in jurisdictions where the use of gestational carriers is restricted, or whose own personal views and beliefs lead them to favor a uterus transplant.
ASRM supports further development of uterus transplantation as a therapeutic option and wishes to emphasize the need to move forward with caution and appropriate preparation. Work in this area should take place only under the oversight of an Institutional Review Board, and only in centers that can gather a strong multidisciplinary team, including a Reproductive Endocrinologist. Such centers should also have the resources for the in-depth training and preparation required to perform this very specialized procedure and take care of these patients.
ASRM is in the process of assembling a team of experts to develop a comprehensive guidance document that will allow potential programs the ability to understand the requirements for establishing this service and to assess the resources needed for considering this option. As with all our patients seeking to build their families, it is important to understand the full array of options available to them, including adoption, gestational carriers, and child-free living.